Xiang Wang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
LncRNA MIR181A1HG Deficiency Attenuates Vascular Inflammation and Atherosclerosis.
Journal: Circulation research
Published: March 06, 2025
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients.
Journal: Frontiers in oncology
Published: April 30, 2021
Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma.
Journal: Frontiers in immunology
Published: March 25, 2020
RS 504393 inhibits M-MDSCs recruiting in immune microenvironment of bladder cancer after gemcitabine treatment.
Journal: Molecular immunology
Published: November 24, 2018
miRNA‑26a‑5p and miR‑26b‑5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.
Journal: Oncology reports
Published: October 11, 2017
Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 07, 2017
High CD4⁺ T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancer.
Journal: International journal of clinical and experimental pathology
Published: July 02, 2015
Chemotherapy sorting can be used to identify cancer stem cell populations.
Journal: Molecular biology reports
Published: May 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026